News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Amphenol Stock Rises 20% in 6 Months: Is There More Room for Growth?
Finviz·2026/03/05 18:33
Flagstar Bank's IDR Upgraded to 'BB+' by Fitch, Outlook Remains Stable
Finviz·2026/03/05 18:33
ICF Stock Declines 5.2% Since Q4 Earnings and Revenue Miss
Finviz·2026/03/05 18:33
PEPE Hovers at Critical $0.053414 Support as $432M Volume Surge Tightens Breakout Watch
Cryptonewsland·2026/03/05 18:33
Lluvias en Argentina vuelven a mejorar condiciones para soja y maíz: Bolsa Cereales
101 finance·2026/03/05 18:33
The Biggest Launch In Crypto History – Analysts Project BlockDAG Market Cap to Hit $1.2bn
BlockchainReporter·2026/03/05 18:30
Japanese Fintech Goes Live On XRP Ledger As ETFs Climb
DailyCoin·2026/03/05 18:27
Dell's ISG Revenue Growth Strengthens: Will the Momentum Continue?
Finviz·2026/03/05 18:27
DraftKings Pushes Into Prediction Markets: A New Growth Lane?
Finviz·2026/03/05 18:27
Oracle plans thousands of job cuts as data center costs rise, Bloomberg News reports
101 finance·2026/03/05 18:24
Flash
22:12
All three major U.S. stock indexes closed lower, while U.S. cybersecurity stocks strengthened.格隆汇 March 6｜The three major US stock indexes closed down collectively, with the Dow Jones falling 1.61%, the S&P 500 index down 0.57%, and the Nasdaq down 0.26%. Major technology stocks were mixed, with Microsoft rising over 1%, Nvidia, Netflix, Amazon, and Intel posting slight gains; Meta fell over 1%, while Apple, Tesla, and Google saw slight declines. US cybersecurity stocks strengthened, with Okta up 11%, CrowdStrike up over 4%, and Datadog up over 3%.
22:08
Simon Property Group announces completion of amendments, restatements, and extensions to existing credit arrangementsThe latest maturity date for this financing instrument has been set for June 30, 2030. It is worth noting that the agreement includes an optional renewal clause, allowing the company to further extend the term to June 30, 2031.
22:07
According to the latest public documents from the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Contineum Therapeutics Inc. has launched a new stock offering plan.The company plans to publicly offer its Class A common stock through the underwriter Leerink Partners, with a maximum fundraising scale of up to 100 million USD. This financing plan aims to provide funding support for the company's clinical-stage research and development projects, further advancing the development process of its drugs for the treatment of neurological diseases. Specific issuance terms, including the offering price, number of shares, and final fundraising scale, will be determined based on market conditions.